Delivery Order SPE2DR25D2104-SPE2DR26F3SWS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,781.32 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order was established on December 31, 2025, with an ultimate completion date of January 2, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,260.01 on December 4, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units per pack). This firm fixed price delivery order, valued at $4,035.65, represents a non-set-aside competitive award with an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract carries a ceiling value of $1,288.24 and has a firm fixed price structure with an ultimate completion date of November 17, 2025. The award was issued from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,394.14 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and utilizes firm fixed pricing with no set-aside designation. The award represents a competitive procurement action supporting federal medical supply requirements, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) valued at $2,995.40. This competitively awarded, firm fixed-price delivery order was issued on December 18, 2025, with an ultimate completion date of December 19, 2025. The contract represents a small-value pharmaceutical procurement executed under DLA's medical supply chain operations, with performance to be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,895.87 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector kits (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of June 10, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SWSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. This delivery order represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), is a leading pharmaceutical distributor that provides comprehensive medical supply support to military healthcare systems worldwide. The IDC vehicle enables efficient procurement of essential pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/5/26 |